Sunday - May 24, 2026
Goodwin Guides Apnimed on Strategic Monetization of Shionogi-Apnimed Sleep Science Joint Venture Stake for $150 Million and Royalties
April 29, 2026
BOSTON, Massachusetts, April 29 [Category: BizLaw/Legal] -- Goodwin, a law firm, issued the following news release:

* * *

Goodwin Guides Apnimed on Strategic Monetization of Shionogi-Apnimed Sleep Science (SASS) Joint Venture Stake for $150 Million and Royalties

*

The Life Sciences team guided Apnimed, Inc. on the sale of its 50% ownership stake in Shionogi-Apnimed Sleep Science, LLC (SASS) to its joint venture partner, Shionogi & Co., Ltd. . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products